ANDOVER, Mass., June 09, 2016 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that enable advanced processes and improve productivity, announced today the successful repricing of its existing secured term loan. The lenders have agreed to an amendment which results in a reduction of the interest rate spread on the term loan by 50 basis points from LIBOR plus 4.00% to LIBOR plus 3.50% with a 0.75% floor on LIBOR.
In addition, the Company repaid $50 million in principal on the term loan reducing the outstanding principal amount to $730 million.
The proceeds of the term loan were used to fund MKS’ acquisition of Newport Corporation which closed on April 29, 2016. The term loan is rated BB by S&P and Ba2 by Moody’s.
“We are very pleased that we were able to quickly capitalize on improving market conditions coupled with strong lender demand to reprice our term loan and reduce our ongoing interest expense. At the same time, by implementing post-transaction tax-planning opportunities, we repatriated $50 million with minimal tax from our international operations and utilized these funds to reduce our principal outstanding to $730 million. This demonstrates our commitment to deleveraging our balance sheet and minimizing our cost of capital,” said Seth H. Bagshaw, Chief Financial Officer.
Barclays and Deutsche Bank acted as joint arrangers for the term loan repricing and amendment.
About MKS Instruments
MKS Instruments, Inc. is a global provider of instruments, subsystems and process control solutions that measure, control, power, monitor, and analyze critical parameters of advanced manufacturing processes to improve process performance and productivity. Our products are derived from our core competencies in pressure measurement and control, materials delivery, gas composition analysis, control and information technology, power and reactive gas generation, vacuum technology, photonics, lasers, optics and motion control. Our primary served markets include semiconductor capital equipment, industrial manufacturing, environmental, medical, life sciences and scientific research.
